Bosuvi 400 mg (Bosutinib 400 mg)

Bosuvi 400 mg, or Bosutinib 400 mg, is a kinase inhibitor that has been approved for treating adult patients with chronic myelogenous leukemia (CML) in the newly diagnosed chronic phase, as well as in the chronic, accelerated, or blast phase with resistance or intolerance to prior therapies.

Bosutinib Dosage: 

To treat newly-diagnosed chronic phase Ph+ CML, the recommended dose is 400mg taken orally once daily with food.

For chronic, accelerated, or blast phase Ph+ CML patients who have previously received therapy but developed resistance or intolerance, the recommended dose is 500mg taken orally once daily with food.

If the patient does not achieve a complete hematologic, cytogenetic, or molecular response and experiences no Grade 3 or greater adverse reactions, the dosage may be increased by 100mg once daily, up to a maximum of 600mg daily.

The dosage should be adjusted as necessary based on observed toxicity or organ impairment.

Bosutinib 400 mg price in India:

Buy Bosutinib online, the price of Bosutinib is only 2% of its price in the United States.

Bosutinib Side Effects: 

If you are taking Bosutinib, it is possible that you may experience various side effects, and it is important to seek immediate medical assistance if you do. These side effects may include stomach pain, nausea, vomiting, diarrhea, or blood in your stools. Additionally, Bosutinib can cause low blood cell counts, such as platelet, red blood cell, and white blood cell counts, which your doctor will monitor during treatment.

Bosutinib may also lead to liver problems, heart problems, fluid retention, and kidney problems. If you experience symptoms such as jaundice, dark urine, shortness of breath, chest pain, swelling in your hands, ankles or feet, changes in urination patterns, or unexpected bleeding or bruising, you should contact your doctor immediately.

Common side effects of Bosutinib in patients with CML include diarrhea, rash, nausea, stomach pain, vomiting, fatigue, liver problems, respiratory tract infections, fever, headache, and changes in certain blood tests. Your doctor may perform blood tests during your treatment to monitor for any changes.

Bosutinib PI:

For more information on prescribing, please refer to the "FDA Prescribing Information."